Prosecution Insights
Last updated: October 04, 2026

Lumicks Ca Holding B V

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Lumicks Ca Holding B V currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio shows a highly concentrated prosecution strategy, as evidenced by the presence of only 1 pending office action. This matter is distributed across 1 distinct examiner and 1 distinct art unit, indicating a narrow scope of current USPTO engagement.

The busiest examiner for the company is KELLY, ROBERT M, who is responsible for the pending matter currently on record. This examiner's workload represents the entirety of the company's active prosecution pipeline. Because the busiest examiner pending count is 1, there is no internal competition for resources or attention across different examiners for this entity.

The alignment of the 1 distinct examiner with the 1 distinct art unit suggests that the company's current legal efforts are localized within a specific technical niche. Practitioners can expect a streamlined communication path, as all active matters reside with a single individual. This concentration simplifies the management of deadlines and examiner interviews for the outstanding office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KELLY, ROBERT M 1 74.1% +24.6%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18725439 SELECTING FORCES FOR MEANS AND METHODS INVOLVING CELLULAR AVIDITY KELLY, ROBERT M —

Top Art Units

Art UnitApps
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18725439 SELECTING FORCES FOR MEANS AND METHODS INVOLVING CELLULAR AVIDITY KELLY, ROBERT M 1657 §112 Non-Final OA — Pending Jun 28, 2024

Managing Lumicks Ca Holding B V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month